Compare Chitose Internasional Tbk. (CINT) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chitose Internasional Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Chitose Internasional Tbk. trades at Rp173 (market cap 176B, 169.4K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 71.5× Chitose Internasional Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (235.2K versus 169.4K). Which is the better fit depends on your goals.
| CINT | TSPC | |
|---|---|---|
Market Cap | 176B | 12.58T |
Volume | 169.4K | 235.2K |
Lot | 1.69K | 2.35K |
Turnover | 29.86M | 649.94M |
Average Price | 176.25 | 2,763.37 |
Value | 29.86M | 649.94M |
Indicative Equilibrium Price | — | 2,780 |
Indicative Equilibrium Volume | — | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chitose Internasional Tbk.
PT Chitose Internasional Tbk (the Company) formerly PT Chitose Indonesia Manufacturing was established based on Notarial Deed No. 21 dated June 15, 1978 of Widyanto Pranamihardja, S.H., notary in Bandung. The name was changed to PT Chitose Internasional on October 4, 2013. The company with brand Chitose has a high market share in all product categories, including folding chair, hotel, restaurant, food coourt, office and working chair and chair school.
Read more on CINT →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
